Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women

Breast Cancer Research and Treatment

Volumn 139, Issue 3, 2013, Pages 833-843

  Gabriel, Courtney A ^a   Mitra, Nandita ^b   Demichele, Angela ^c   Rebbeck, Timothy ^b  

^a Penn Medicine in Cherry Hill   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Genotype; Hormone replacement therapy; Progesterone receptor; Risk

Indexed keywords

ESTROGEN; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PARITY; PGR GENE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PHILADELPHIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE;

EID: 84879800390     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2592-0     Document Type: Article

References (39)

1. Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276-285. doi: 10.1056/NEJM200101253440407
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291(14):1701-1712. doi: 10.1001/jama.291.14. 1701
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288(3):321-333 [pii] joc21036
4. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362(9382):419-427 [pii] S0140673603140652
5. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR (2003) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 289(24):3254-3263. doi: 10.1001/jama.289.24.3254
6. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283(4):485-491 [pii] joc91096
7. Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92(4):328-332
8. Olsson HL, Ingvar C, Bladstrom A (2003) Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer 97(6):1387-1392. doi: 10.1002/cncr.11205
9. Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B (2004) Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer 109(5):721-727. doi: 10.1002/ijc.20016
10. Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F (2005) Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol 96(2):95-108. doi: 10.1016/j.jsbmb.2005.02.014
11. L'Hermite M, Simoncini T, Fuller S, Genazzani AR (2008) Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 60(3-4):185-201. doi: 10.1016/j.maturitas.2008.07.007
12. Graham JD, Clarke CL (2002) Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4(5):187-190
13. http://www.ncbi.nlm.nih.gov/SNP/snp-ref.cgi?locusId=5241
14. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC (2005) Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 97(1):51-59. doi: 10.1093/jnci/dji007
15. Risch HA, Bale AE, Beck PA, Zheng W (2006) PGR +331 A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15(9):1738-1741. doi: 10.1158/1055-9965.EPI-06-0272
16. Rockwell LC, Rowe EJ, Arnson K, Jackson F, Froment A, Ndumbe P, Seck B, Jackson R, Lorenz JG (2012) Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers. Am J Hum Biol 24(1):42-51. doi: 10.1002/ajhb.21233
17. O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K, Rebbeck TR, Ahmed S, Dunning AM, Gregory CS, Shah M, Webb PM, Spurdle AB (2011) Progesterone receptor gene variants and risk of endometrial cancer. Carcinogenesis 32(3):331-335. doi: 10.1093/carcin/bgq263
18. Lee E, Hsu C, Haiman CA, Razavi P, Horn-Ross PL, Van Den Berg D, Bernstein L, Le Marchand L, Henderson BE, Setiawan VW, Ursin G (2010) Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach. Carcinogenesis 31(8):1392-1399. doi: 10.1093/carcin/bgq113
19. Xu WH, Long JR, Zheng W, Ruan ZX, Cai Q, Cheng JR, Xiang YB, Shu XO (2009) Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population. Cancer 115(12):2693-2700. doi: 10.1002/cncr.24289
20. Treloar SA, Zhao ZZ, Armitage T, Duffy DL, Wicks J, O'Connor DT, Martin NG, Montgomery GW (2005) Association between polymorphisms in the progesterone receptor gene and endometriosis. Mol Hum Reprod 11(9):641-647. doi: 10.1093/molehr/gah221
21. Cramer DW, Hornstein MD, McShane P, Powers RD, Lescault PJ, Vitonis AF, De Vivo I (2003) Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. Am J Obstet Gynecol 189(4):1085-1092 [pii] S0002937803005179
22. Su MT, Lee IW, Chen YC, Kuo PL (2011) Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population. J Assist Reprod Genet 28(3):239-243. doi: 10.1007/s10815-010-9510-8
23. Schweikert A, Rau T, Berkholz A, Allera A, Daufeldt S, Wildt L (2004) Association of progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod Biol 113(1):67-72. doi: 10.1016/j.ejogrb.2003.04.002
24. Fernandez LP, Milne RL, Barroso E, Cuadros M, Arias JI, Ruibal A, Benitez J, Ribas G (2006) Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study. Int J Cancer 119(2):467-471. doi: 10.1002/ijc.21847
25. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K (2004) Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64(24):8891-8900. doi: 10.1158/0008-5472.CAN-04-1256
26. Johnatty SE, Spurdle AB, Beesley J, Chen X, Hopper JL, Duffy DL, Chenevix-Trench G (2008) Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Res Treat 109(1):91-99. doi: 10.1007/s10549-007-9627-3
27. Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM (2006) Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomarkers Prev 15(4):675-682. doi: 10.1158/1055-9965.EPI-05-0679
28. Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL (2007) Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev 16(3):444-450. doi: 10.1158/1055-9965.EPI-06-0800
29. Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE (2009) Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. Am J Epidemiol 170(10):1241-1249. doi: 10.1093/aje/kwp298
30. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kampjarvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schurmann P, Dork T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18(5):1610-1616. doi: 10.1158/1055-9965.EPI-08- 0745
31. Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E (2008) Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 17(7):1751-1759. doi: 10.1158/1055-9965.EPI-08-0168
32. Bunin GR, Baumgarten M, Norman SA, Strom BL, Berlin JA (2005) Practical aspects of sharing controls between case-control studies. Pharmacoepidemiol Drug Saf 14(8):523-530. doi: 10.1002/pds.1130
33. Strom BL, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Rebbeck TR (2006) Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 164(8):775-786. doi: 10.1093/aje/kwj316
34. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA (2001) Haplotype tagging for the identification of common disease genes. Nat Genet 29(2):233-237. doi: 10.1038/ng1001-233
35. Hochberg YBY (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57(1):289-300
36. Schaid DJ (2004) Evaluating associations of haplotypes with traits. Genet Epidemiol 27(4):348-364. doi: 10.1002/gepi.20037
37. Breast Cancer Facts & Figures 2009-2010. American Cancer Society, Inc. http://www.cancer.org/docroot/STT/STT-0.asp
38. Wang Y, Localio R, Rebbeck TR (2004) Evaluating bias due to population stratification in case-control association studies of admixed populations. Genet Epidemiol 27(1):14-20. doi: 10.1002/gepi.20003
39. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Potti A, Blackwell KL (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20):3324-3330